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Abstract Chronic obstructive pulmonary disease (COPD)
is a heterogeneous disease that is characterized by chronic
airﬂow limitation. Unraveling of this heterogeneity is chal-
lengingbutimportant,becauseitmightenablemoreaccurate
diagnosis and treatment. Because spirometry cannot distin-
guishbetweenthedifferentcontributingpathwaysofairﬂow
limitation,andvisualscoringistime-consumingandproneto
observer variability, other techniques are sought to start this
phenotyping process. Quantitative computed tomography
(CT) is a promising technique, because current CT tech-
nologyisabletoquantifyemphysema,airtrapping,andlarge
airway wall dimensions. This review focuses on CT quan-
tiﬁcation techniques of COPD disease components and their
current status and role in phenotyping COPD.
Keywords Computed tomography  Airway remodeling 
Pulmonary emphysema  Chronic obstructive pulmonary
disease  Quantitative CT
Introduction
Chronic obstructive pulmonary disease (COPD) is cur-
rently simply deﬁned as chronic airﬂow limitation that is
not fully reversible; however, in reality COPD is a com-
plicated group of disorders with a range of pathological
changes in the lung, extrapulmonary effects, and comor-
bidities, which all may contribute to the severity of the
disease [1–5]. In the lungs, parenchymal destruction
(emphysema), small airways disease, large airways disease,
and possibly other factors contribute to the airﬂow limita-
tions in varying degrees. Unraveling of this heterogeneity
is challenging but important, because early detection of
these pathologies might enable more accurate and earlier
diagnosis and might lead to more speciﬁc therapeutic
options. Quantitative computed tomography (CT) may be a
highly interesting modality to detect these pathologies in
vivo, because its separate analysis of disease components
may allow morphologic phenotyping and visual evaluation
of CT images for pathology is time-consuming and prone
to considerable observer variability [6].
During the past decades, quantitative CT has increas-
ingly been used to assess lung structure [7], and consid-
erable research efforts have been devoted to emphysema
quantiﬁcation. In addition, several research groups have
worked on tools to quantify large airway wall morphology.
There are strong suggestions that emphysema-dominant
and airway wall thickening-dominant groups of COPD
patients can be separated by quantitative CT [8]. Until
recently, only little work has been presented on the quan-
tiﬁcation of small airways disease, even though the small
airways are the most important site of airﬂow obstruction
in COPD [9–12]. This review summarizes and illustrates
the current status of CT quantiﬁcation methods for the
several COPD components, and we discuss the current
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DOI 10.1007/s00408-011-9353-9status and future possibilities of phenotyping COPD by
quantitative CT (Table 1).
Emphysema Quantiﬁcation
Pulmonary emphysema involves alveolar wall destruction
and apoptosis of epithelial and endothelial cells caused by
repeated injury and repair after inhalation exposure of
cigarette smoke and other noxious particles [1]. Emphy-
sema can be subdivided into centrilobular, panlobular,
bullous, and paraseptal emphysema, which show different
distribution throughout the lung; for example, the lower
lobe predominance of panlobular emphysema in alfa-1-
antitrypsin deﬁciency (AATD) versus the distal and sub-
pleural distribution of paraseptal emphysema [13]. This
difference in distribution may be of importance when sin-
gle CT images are evaluated; however, in volumetric
assessment of the lungs this is not. In assessment of the
emphysema extent, quantitative analysis should be pre-
ferred over visual scores [14], because quantitative
assessment of emphysema provides a continuous instead of
a categorical score, which is important in disease follow-
up. Emphysema quantiﬁcation has been shown to be highly
reproducible [15–18]; however, data on the limits of
agreement, which are important to deﬁne actual increase in
longitudinal use, are currently still limited. Nevertheless, it
is to be expected that when correction for lung volume is
applied, quantitative CT assessment of emphysema will be
near perfectly reproducible.
The ﬁrst study to quantify emphysema severity with CT
was performed by Hayhurst and colleagues, who showed
that Hounsﬁeld Unit (HU) frequency distribution curves of
patients with histologically proven emphysema signiﬁ-
cantly differed from patients without emphysema [19].
Four years later, an objective method that highlights voxels
below a ﬁxed threshold, the ‘‘density mask,’’ was intro-
duced (Fig. 1)[ 20]. Emphysema severity is generally
quantiﬁed as the ‘‘low attenuation area’’ (LAA) in the lung
with HU less than a ﬁxed density threshold (e.g., -950
HU; LAA-950). Another method is using the nth cutoff-
percentile in the attenuation distribution curve, which
provides the density value in HU under which n% of the
voxels is distributed [7, 21, 22]. Over time, several density
thresholds have been proposed in the literature to separate
emphysematous from nonemphysematous lung [7, 21–23].
The ﬁrst density threshold proposed by Muller and
coworkers [20] was at -910 HU, because this cutoff value
yielded the best correlation between emphysema in resec-
ted lung tissue and CT measurements in contrast-enhanced
10-mm-thick slices, obtained on a single-slice scanner.
Gevenois et al. later reported the strongest pathologic
correlation with emphysema at macroscopic [24] and
microscopic [25] level at a threshold of -950 HU in 1-mm
noncontrast-enhanced high-resolution ﬁltered images.
More recently, Madani et al. observed that thresholding at
-960 to -980HU best reﬂects the extent of emphysema
for multidetector CT (MDCT) scans with slice-thicknesses
of 1.25, 5.0, and 10.0 mm, at 20 or 120 mAs [23]. These
thresholds yielded the strongest correlation with macro-
scopic and microscopic extent, although all thresholds
lower than -910 HU were signiﬁcantly correlated with
Table 1 Current status and future directions of quantitative computed
tomography in COPD
Current status It is now technically possible to quantify
emphysema, air trapping, and large airway
dimensions on CT scans of COPD patients.
Previous studies have shown good correlation
with histology and clinical measures. In
general, more extensive evidence is available
for CT emphysema quantiﬁcation; less
evidence is available for large airway




Future studies could further address the
inﬂuence of CT scanning parameters and
volume correction during acquisition
Future clinical
application
More studies are needed on the practical value
of quantitative CT for early diagnosis,
prediction of outcome, and disease
phenotyping
Fig. 1 Quantitative
emphysema measure. Axial CT
images of the thorax in
inspiration showing emphysema
(left) and densitometry overlay
at a threshold of -950
Hounsﬁeld Units (right). Voxels
with attenuation below the set
threshold are colored white
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123histopathological indices [23]. For longitudinal emphy-
sema studies, percentile densitometry with the 15th per-
centile is reported to be recommended [26]. Recently,
Madani et al. demonstrated that the ﬁrst percentile showed
the highest correlation with macroscopic and microscopic
emphysema in 1-mm MDCT images [23]. However, all
cutoffs below the 18th percentile were signiﬁcantly corre-
lated with histopathology [23]. The above shows that there
is a range of approaches possible, and until today there is
no ﬁnal consensus regarding the optimal cutoff in percen-
tile method or threshold value, especially not for low-dose
multidetector CT scans [27].
Factors that Inﬂuence Quantitative Measurements
Densitometry can be inﬂuenced not only by the applied
percentile or density threshold, but also by image recon-
struction algorithm [28–31], section thickness [28, 32],
inspiration level [15, 33], scanner/study centre [15], gravity
[34] and radiation dose [35]. Madani and colleagues
recently showed signiﬁcant differences in emphysema
measurements at varying inspiration levels, but they sug-
gested that this may not be clinically relevant above 90%
of vital capacity for %LAA-950HU, or above 80% of vital
capacity for the 1st percentile method [33]. Bakker et al.
has stated that CT densitometry is highly reproducible, and
interscan variability of emphysema measurements largely
originates from differences between scanners and severity
of disease, especially when corrected for differences in
total lung volume [15]. Therefore, it is argued that scans
should be corrected for lung volume [36, 37]. When mul-
tiple scanners are involved, scans can be corrected by
calibrating for tracheal air [38]. To correct for the physi-
ological ventrodorsal gradient in lung attenuation due to
gravity, an automatic robust linear ﬁt correction is sug-
gested [34]. Currently, corrections are not widely applied.
Further, application of dose reduction is important. When
the radiation dose is reduced, the signal-to-noise ratio is
lowered which could possibly lead to unreliable quantita-
tive measurements. Studies on the effects of radiation dose
are not conclusive; several studies reported that dose
reduction can be applied without clinical importance
[32, 39–41], but others did found a signiﬁcant difference in
quantitative emphysema measurements between high-dose
and low-dose [35]. Additionally, to lessen the problem of
increased noise in low-dose scanning, the application of a
noise reduction ﬁlter may be useful [42]. Taken together,
low dose scanning is feasible, as long as scanning protocol
is taken into account in comparison of results between
different studies or in follow-up.
Besides the technical factors that interact with emphy-
sema quantiﬁcation, co-existing high-density lung disease
[43, 44] and low-density air trapping (Fig. 2)[ 10, 45] may
inﬂuence the quantitative assessment of emphysema. Inter-
stitial lung disease (i.e. ﬁbrosis) or air trapping can alter the
lung attenuation, ‘masking’ or aggravating emphysema
measurements. This emphasizes the necessity of combined
analysis of the different COPD components (Table 2).
Less Commonly Used Quantiﬁcation Methods
Several other quantiﬁcation methods have been reported,
but these are less often used. Coxson et al. [46] described a
method in which the remaining amount of lung tissue is
quantiﬁed. They expressed lung inﬂation as ml of air per
gram lung tissue, and showed that emphysematous lesions
below and above 5 mm diameter corresponded with
6.0–10.2 and [10.2 ml air per gram lung tissue,
Fig. 2 Quantitative air trapping measure. Axial CT images of the
thorax in inspiration (left) and expiration (middle, left) showing air
trapping as sharply deﬁned areas with less than normal increase in
lung attenuation and lack of volume reduction after expiration
(middle), and the densitometry overlay at a threshold between -860
HU and -950 HU (right). Voxels with attenuation within this range
are colored white
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123respectively. Others have developed more technical, tex-
ture-based quantiﬁcation methods, applying parenchymal
classiﬁcations and a large number of independent tissue
features [47–52]. Texture-based measurements were
reported to correlate signiﬁcantly better with PFT than
density-based measurements [51, 52]. Finally, a fractal-
based concept was introduced to assess the size distribution
of low attenuation regions. Mishima et al. determined the
slope of the cumulative frequency-size distributions of
areas below -960 HU on a log–log scale (D-value) [53],
and based on their results they suggest that the D-value is a
robust parameter and powerful index of terminal airspace
enlargement, and a potential method of emphysema
quantiﬁcation [53]. Its pathological validity is questioned
[54], but Yuan et al. recently showed that D-value is
independently and signiﬁcantly correlated with histological
measurements of emphysema and that the combination of
cluster analysis and lung densitometry provides a more
accurate result than either measure alone [44].
In conclusion, CT scanning is commonly used for
emphysema quantiﬁcation, and pathological correlation
studies are available. However, the debate about both the
most appropriate scan technique and algorithm has not
been settled yet. As long as different techniques and set-
tings are used, strict comparison of studies should be per-
formed with great caution, because many factors inﬂuence
the automated quantitative results.
Large Airway Measurements
Large airways can be thickened in COPD, an abnormality
shown to correlate with pulmonary function tests [55]. It
also has been shown that bronchial wall thickening is an
independent determinant of airﬂow obstruction in COPD
subjects [56, 57]. Structurally, the changes in proximal
airways of COPD subjects involve squamous metaplasia of
epithelium and mucus hypersecretion [1]. It has been
suggested that thickening of the wall of larger airways
reﬂects small airway abnormalities [58], but whether large
airway wall thickening merely reﬂects small airways dis-
ease or is an independent morphologic phenotype of COPD
remains to be determined.
Initial studies on large airway quantiﬁcation relied on
manual tracing of airways on CT images [59], but devel-
opments in scanner technology led to the introduction of
multiple techniques [60–69]. The most widely used method
in airway measurements is the ‘‘full-width-at-half-max-
imum’’ (FWHM) principle. Brieﬂy, the FWHM technique
calculates the x-ray attenuation values along rays placed
from the lumen center outwards in all directions (Fig. 3).
The airway wall boundaries are considered to be at the
location where attenuation is halfway to the maximum on
the lumen side and halfway to the minimum on the
parenchymal side (Fig. 4)[ 64, 70]. From the airway wall
delineations, different parameters, such as wall thickness,
lumen area, wall area percentage, and airway perimeters,
can be calculated [71]. Although the FWHM technique is
standardized and straightforward, it systematically over-
estimates airway wall area, especially in small airways
[64]. Several other techniques were described to increase
accuracy. First, a phantom study showed greater accuracy
compared with FWHM in measuring the airway inner and
outer radius of thin-walled airways with the use of a
maximum-likelihood algorithm on the gray level along a
calculated ray [60]. Second, Saba et al. reported a method
of ellipse-ﬁtting to the airway lumen and wall of a phantom
that signiﬁcantly improves estimation of the luminal edges
and is able to estimate airway geometry to within 4 degrees
in tilt of obliquely cut airways [61]. Third, a score-guided
erosion algorithm showed signiﬁcantly lower overestima-
tion of airway wall area in a phantom and excised pig lung
compared with manual delineation. Their method com-
bined an edge-ﬁnding algorithm with the knowledge that
airways are roughly circular and of high density to lung
parenchyma [62]. Last, Weinheimer et al. presented an
integral based method by which the blurring effect of CT,
especially present in small objects, is minimized. They
showed that their method performed much better than the
FWHM method in a silicon tube phantom. Also, their
method proved repeatable in pigs and was able to dis-
criminate between smokers and nonsmokers in their trial
[63].
Using multiplanar reconstruction, Hasegawa etal. showed
thatairwaywalldimensionsatthesixthgenerationweremore
closelyassociatedwithlungfunctionthandimensionsofmore
proximal generations [67]. This ﬁnding is supported by
Table 2 Challenges to be solved in quantitative computed tomography
in COPD
Challenge Speciﬁc study
Multicenter studies with CT
scanners from multiple vendors
Suitability and inﬂuence of
tracheal air correction on the
quantitative measures of
emphysema and air trapping
Longitudinal data Interscan variability and limits of
agreement of the quantitative
measures. Methods of proper
lung volume control or volume
standardization




Lack of consensus on which
measures to use, multiple
software tools
Comparison of the available
quantitative measures against
reference standards
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123Achenbach and colleagues who assessed airway wall
dimensions in smokers with COPD and never smokers
with 3D software [68]. They reported moderate correlations
(-0.56\r\-0.62) between airway wall measurements
and airﬂow obstruction (FEV1 and %predictedFEV1), and
demonstrated stronger correlations when only small airways
were analyzed. Matsuoka et al. [69] were the ﬁrst to perform
airway measurements in expiration, using phantom-validated
3D software. The authors demonstrated that luminal area in
expirationcorrelatedmorecloselywithairﬂowlimitationthan
did measurements in inspiration and that the highest correla-
tion was found for the expiration to inspiration ratio of lumen
area. Furthermore, they showed that the correlation
improved from the third to the ﬁfth generation (maximum
0.70\r\0.72) [69]. These results extend the ﬁnding by
Hasegawaandsuggestthatbothairwaywallandluminalarea
show stronger relations to airﬂow limitation in more periph-
eral airways. Recently, bronchial wall attenuation was intro-
duced as another index for airway abnormality in COPD
subjects; in thin walled structures, such as more peripheral
airways,thispeakwallattenuationisthoughttorepresentboth
airway wall density and wall thickness [72, 73]. In this study,
Yamashiro et al. further solidiﬁes the observation of stronger
correlations in more peripheral airways, both for the airway
wall attenuation, airway wall dimensions, and luminal area
[73].
Factors that Inﬂuence Quantitative Measurements
Technically, quantitative airway measurements may be
inﬂuenced by partial volume averaging [74]. Furthermore,
the applied reconstruction kernel signiﬁcantly affects air-
way wall and luminal measurement results of the FWHM
method, whereas slice thickness and ﬁeld of view (FOV)
apparently do not [75]. Contrarily, it has been reported by
Fig. 4 Graphical illustration of the full-width-at-half-maximum
(FWHM) method. An illustration of the attenuation proﬁle along an
outwards ﬂowing ray from the luminal center-point through the
airway wall (Fig. 3). In the full-width-at-half-maximum (FWHM)
method, the inner and outer airway wall boundaries are assumed
halfway to the maximum on the lumen side and halfway to the
minimum on the parenchymal side (half-maximum), respectively.
The airway wall thickness is assumed the distance between both
points (full-width)
Fig. 3 Quantitative measurement of the large airway dimensions. An
axial CT image of the right lung at the level of the upper right apical
bronchus (upper left). A magniﬁed image of this airway is shown with
rays ﬂowing out of a center point in the airway lumen in all directions,
as well as the deﬁned inner and outer edge of the airway wall (upper
right). Additionally, two examples are shown with a thickened airway
wall (lower left, black arrow) and a normal airway wall (lower right,
black arrow). The wall area percentage (%WA) is 84% and 65%,
respectively
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123Achenbach et al. that the pixel size does affect the accuracy
of the FWHM method [76]. Reconstruction kernel inﬂu-
ence was further investigated by Schmidt et al. who
reported minor bias in measurements across soft and hard
reconstructions [77]. Lowering the radiation dose was
found to affect FWHM-based measurements of lumen
diameter and wall thickness in pig airways [78]. Contrarily,
others found no inﬂuence of radiation dose on the accuracy
of their algorithm in low-dose scans at 50 mAs [79]. Evi-
dence on the effect of lung volume on quantitative
assessment of airway dimensions in humans is lacking.
Lastly, longitudinal data for the different airway quantiﬁ-
cation techniques are limited, but variability between CT
measurements may be substantial and impair measure-
ments, especially in smaller airways [80].
In conclusion, the wall of larger airways is directly
visible on CT and can be thickened in COPD patients.
Quantiﬁcation methodology has developed during the past
decade into automated 3D-programs. Future studies are
required to determine the pathological validity of the newer
3D quantiﬁcation techniques, and further research should
investigate the inﬂuence of CT scan parameters and inter-
scan reproducibility of the different airway quantiﬁcation
methods available.
Small Airways Measurements
The most important site of airﬂow obstruction in COPD are
the airways smaller than 2 mm [11, 12]. Structurally, this
involves airway wall thickening, airway narrowing, peri-
bronchial ﬁbrosis, and luminal inﬂammatory mucous exu-
date [1]. These small airways cannot be visualized directly
using current CT scanners, but the presence of air trapping
on expiratory CT scans can be used as an indirect sign to
evaluate small airways dysfunction. Air trapping is deﬁned
as less than normal increase in lung attenuation and lack of
volume reduction after expiration (Fig. 2)[ 13]. Quantiﬁ-
cation of air trapping is challenging in COPD patients,
because it should be separated from air remaining in
emphysematous spaces after exhalation [10]. In addition,
air trapping is an unspeciﬁc phenomenon, because it is
reported in nonobstructive smokers and healthy individuals
with normal PFT as well [81–86]. Finally, there is no
pathological reference available, because air trapping is an
in vivo phenomenon.
CT quantiﬁcation of air trapping has not been widely
used in COPD subjects. Recently, the percentage of lung
voxels below -856 HU in expiration has been introduced
as a measure of air trapping in COPD [87]. This expiratory
threshold of -856 HU is a conversion of 6.0 ml/g lung
inﬂation in inspiration [46], and it has been has been used
before in air trapping quantiﬁcation in asthmatic children
[88]. The drawback of this single-threshold method is that
it does not compensate for the inﬂuence of emphysematous
areas; it combines air trapping and emphysema quantiﬁ-
cation into one measure. Previously, the expiratory to
inspiratory ratio of mean lung density (E/I-ratioMLD), as a
measure of air trapping, was shown to correlate
(0.48\r\0.68) with clinical parameters of COPD such
as BODE-index [45]. Yamashiro and colleagues [9] used
the expiratory to inspiratory ratio of lung volume (E/I-
ratioLV) and showed that his volume-ratio correlated
almost perfectly (r = 0.95; p\0.001) with the E/I-
ratioMLD. Nevertheless, this air trapping measures may
clearly be inﬂuenced by the expiratory effort, and scanning
should be performed after standardized instructions.
Matsuoka et al. [10, 89] developed a density-based quan-
tiﬁcation method for air trapping that is designed speciﬁ-
cally to quantify air trapping outside emphysematous areas.
To exclude emphysema, all voxels with attenuation lower
than -950 HU were excluded from inspiration and expi-
ration scans. In these limited lungs, a threshold of -860
HU delivered the highest correlation with spirometry and
RV/TLC. They subsequently calculated the relative volume
change between -860 HU and -950 HU (RVC-860 to
-950) using the formula: RVC-860 to -950 = expiratory
volume between -860 and -950HU—inspiratory volume
between -860 and -950HU. Their measure correlated
signiﬁcantly with lung function parameters of airﬂow
obstruction and air trapping (r = 0.50–0.80) in subjects
with either minimal-to-mild emphysema or moderate-to-
severe emphysema [10]. In a feasibility study, Torigian
et al. [90] attempted to register accurately inspiration and
expiration scans to obtain a colored ‘‘difference-image.’’
Further research into this method is required to improve
precision and accuracy. To date, no comparison of the
published quantitative CT measures of air trapping has
been performed, and the optimal quantitative measure has
yet to be identiﬁed.
Factors that Inﬂuence Quantitative Measurements
Quantiﬁcation of air trapping in expiratory scans is clearly
inﬂuenced by the level of expiration, but the inﬂuence of
suboptimal expiration on air trapping quantiﬁcation has not
been studied. Scanning should be performed after strict
breathing instructions, but standardization of expiration
level also could be achieved by using spirometric-gated
scanning, a technique that is technically cumbersome and
not widely used in clinical practice. It is currently not
known whether such standardization will improve the
repeatability of quantitative assessment of air trapping.
Furthermore, noise in low-dose scans may inﬂuence the
quantitative measurements similar to emphysema quanti-
ﬁcation. At the moment, no noise reduction ﬁlter is
138 Lung (2012) 190:133–145
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noise for air trapping quantiﬁcation. No studies have
addressed section thickness and other scan parameters on
quantitative CT measurements of air trapping. Last, pres-
ence of emphysematous areas may inﬂuence quantitative
assessment of air trapping. Techniques that compensate for
emphysema are theoretically preferred; however, to date no
studies are available that compare corrected and uncor-
rected quantitative CT air trapping measures.
In conclusion, small airways cannot be directly visual-
ized with current CT technology, but air trapping quanti-
ﬁcation at end-expiratory CT scans can be used as an
indirect measure of small airways disease. Literature in this
relatively new research area is still limited, and it is yet
unknown what is the optimal quantitative CT air trapping
method in COPD.
Other Possible Quantiﬁable Abnormalities
The extent of airﬂow limitation in COPD may not be fully
explained by emphysematous tissue loss, small airways
disease, and large airway remodeling alone. Hence, several
other morphologic CT signs (e.g., intrapulmonary airway
collapse [91], tracheobronchomalacia [92], mucous plug-
ging, bronchiectasis, or interstitial lung disease) might be
involved and could possibly be quantiﬁed. However, to our
knowledge, these components have not been investigated
with quantitative CT techniques so far.
Use of Quantitative CT in COPD
Correlation with Disease Parameters
A small number of studies, as summarized below, have
investigated the relationship between quantitative CT
measures and some commonly used clinical measurements.
The number of publications limits the interpretation on
which CT parameters correlated best with a certain clinical
parameter. Quantitative CT emphysema has been shown to
be associated with osteoporosis [93, 94], exercise capacity
(6-minute walk distance, 6MWD) [45, 95], and the BODE
index (a multicomponent parameter that includes BMI,
FEV1, dyspnoe-score and exercise capacity as measured
with the 6MWD) [45, 96]. Additionally, it has been shown
that quantitative CT air trapping is associated with 6MWD
[45] and that quantitative CT measurements of airway wall
thickness and emphysema are associated with exacerbation
frequency in COPD subjects [97]. Also, CT measurements
of emphysema and airway wall thickness are independently
related to patient reported respiratory symptoms [98].
Recently, it has been shown that the combination of
quantitative CT emphysema and CT air trapping explains a
large part of the variation in airﬂow limitation in COPD
[99]. Finally, it has been reported that CT assessed
emphysematous changes correlated with respiratory mor-
tality in various stages of COPD [100]. These are all
interesting ﬁndings that may lead the way to a clinical
application of quantitative CT; however, all studies are
relatively small and need further validation. Future studies
will have to expand the knowledge on the associations
between quantitative CT measures and relevant disease
parameters.
Clinical Application
Possible clinical application of quantitative CT has been
studied in lung volume reduction surgery (LVRS) patients.
Cederlund et al. [101] used densitometry at -950 HU to
separate heterogeneous from homogeneous distribution of
emphysema and suggested further research to determine its
value in patient selection and postoperative outcome in
LVRS. Nakano et al. [102] showed that LVRS candidates
with emphysema distribution in the rind of upper lung
ﬁelds had greater beneﬁt from this treatment than those
with emphysema at other locations. Additionally, Flaherty
et al. found that upper zone emphysema was the best
predictor of FEV1 increase after surgery [103], and
Martinez et al. [104] showed that lower zone predominance
was predictive of mortality. Furthermore, it was demon-
strated that CT measurements of emphysema before LVRS
predict postsurgery cardiopulmonary exercise capacity
[105]. These results all support the promising role of
quantitative CT assessment in patient selection and out-
come prediction in LVRS; however, it is questionable
whether a preoperative radiological measure alone can
sufﬁciently predict functional outcome of LVRS; it is more
likely that CT will serve as an additive tool.
Longitudinal studies regarding both clinical and quan-
titative CT data are important in requiring insight into the
structural changes over time, the contribution of different
disease components to functional decline, and the effect
throughout different stages of the disease. In this area,
quantitative CT measures have been used recently as out-
come measure; Stockley et al. showed that alpha-1-anti-
trypsine augmentation signiﬁcantly reduces CT lung
density decline, which represented emphysema increase
and may therefore reduce mortality risk [106]. Parr et al.
showed that sputum markers of neutrophilic inﬂammation
in COPD correlated with disease progression, indicated as
quantitative CT measures [107]. Using quantitative CT
emphysema measures as outcome variable originates from
the study by Dirksen et al. [108], which showed that spi-
rometry is less sensitive than CT lung density for the
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lined this superiority of quantitative CT over spirometry for
the detection of disease progression in alfa-1-antitrypsine
deﬁciency [109–111]. Other longitudinal studies into CT
emphysema quantiﬁcation provided information that
quantitative measurements of overinﬂation [112] and
emphysema [38] at baseline predict greater decline in lung
function over time. These data illustrate the expanding use
of CT emphysema assessment in longitudinal research, and
it is to be expected that quantitative CT will increasingly be
used to monitor disease progression and therapy effects.
However, although some studies have reported on the
reproducibility of emphysema measurements [15–18],
more knowledge on the limits of agreement is needed
before widespread use of quantitative CT emphysema
measures in longitudinal studies.
Also of interest is the longitudinal assessment of airway
dimensions and air trapping using quantitative CT. Ohara
et al. [113] found that annual changes in airway thickening
correlated with annual decline in lung function; however,
there is very little evidence and certainly no consensus on
howtoobtainandcomparedataonlargeandsmallairwaysin
COPD. Future studies should establish a general approach,
validation against pathology, and elucidate the reproduc-
ibility and limits of agreement of different quantiﬁcation
methods. Additionally, they should provide further data on
the association between clinical parameters and airway wall
thickening and air trapping, and on the predictive value of
these measures for lung function decline.
Possible Role in Phenotyping
It has become a widespread belief that different phenotypes
exist within COPD and that these phenotypes may require
different management and treatment. Quantitative CT
might be a good starting point because well-known rele-
vant pathology can be detected in vivo. Nakano et al. [70]
quantiﬁed the airway wall of the upper right apical bron-
chus and emphysema extent in 114 subjects and found that
both airway dimensions and parenchymal destruction are
independent contributors to lung function. They further
showed that most subjects showed either airway- or
emphysema-dominant disease [8, 70].
Makita et al. showed that emphysema extent varies
widely within the same disease stage, suggesting that there
are subjects with emphysematous disease and small air-
ways disease [114]. Patel et al. provided further evidence
for phenotypes by showing that airway wall thickening and
emphysema dominance follows familial aggregation [57].
Within emphysema, small airway wall thickening has been
shown to occur in both centrilobular and panlobular phe-
notypes, however, is more closely associated with
emphysema and airﬂow limitation in the centrilobular
phenotype [115]. It also has been reported that emphyse-
matous COPD subjects have a different disease phenotype
compared with nonemphysematous COPD subjects; i.e.,
lower spirometry, diffusion constant, radiological scores of
chronic bronchitis, and more sputum lymphocytes [116].
Regarding airway-dominant phenotypes, it has been shown
that COPD subjects with chronic bronchitis had thicker
airway walls than COPD subjects without chronic bron-
chitis [117]. Finally, Alford et al. reported a more mech-
anistically oriented phenotyping method based on
heterogeneity of pulmonary perfusion in emphysema sus-
ceptible smokers [118].
As the literature shows, different characteristics have
been named phenotypes over time. Recently, a clear deﬁni-
tion was proposed to classify COPD subjects in relation to
clinicallymeaningfuloutcomes[119].Inlinewiththis,ithas
been shown that increase in CTemphysema and airway wall
thickness is associated with exacerbation frequency, which
suggests that quantitative CT may help in the identiﬁcation
of subgroups with exacerbations for targeted research or
phenotype speciﬁc therapy [97]. Such phenotyping and
focused intervention is likely to be clinically meaningful;
therapeutic intervention directed against inﬂammation of
airways may be useful in airway dominant COPD; however,
it might be useless or theoretically even harmful in subjects
with an emphysema dominant phenotype. Fujimoto and
Kitaguchi [120, 121] underline this rationale by demon-
strating different responsiveness to drugs in patients with
visual predominant airway, emphysema, or mixed disease.
Futurestudiesshouldprovidemoreevidenceonphenotyping
and clinical outcomes. Currently, large studies, such as
ECLIPSE,COPDgene,andSPIROMICS,areontheirwayto
gather data systematically forCOPD subjectsand toprovide
new information to further unravel this complex disease.
Additional Diagnosis of COPD
With the increased use of CT in both daily practice and
lung cancer screening trials, where pulmonary function
testing is not performed routinely, quantitative CT might
become a useful tool for the detection of new COPD
subjects. First, given the strong relationship between air-
ﬂow limitation and quantitative CT measurements of
emphysema and air trapping [99], quantitative CT may be
used additionally to identify airﬂow obstruction from CT
scans obtained for another reason [122]. Second, CT holds
the potential to predict lung function decline [38, 112] and
to identify COPD cases still in their subclinical stage (i.e.,
normal pulmonary function test) based on morphologic CT
features [38]. However, evidence on the additive value for
COPD detection in CT is still limited and more research is
warranted to further explore this application of CT data.
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Radiation dose and risks are important issues in studies
involving CT imaging. Image noise is an important related
issue for quantitative CT on low-dose scans. Brieﬂy, noise
represents random ﬂuctuations of the measured CT number
in scans; thus, image noise will increase when radiation
dose is lowered. Quantitative CT is possible with low-dose
protocols with effective dose around 0.5-1.5 mSv (annual
background radiation in the United States is around 3 mSv)
[123]. Even when individuals are exposed multiple times
(e.g., lung cancer screening trials), the cumulative dose
remains fairly low. However, risk should always be bal-
anced to expected beneﬁt.
Conclusions
The detection of relevant COPD phenotypes is a chal-
lenging and exciting research priority. Since quantiﬁcation
techniques have been improved during the past decades,
CT can now measure the well-known disease components
in COPD, such as emphysema, small airways disease, and
large airways disease; this makes quantitative CT very
promising in COPD research. However, a lot of work
remains, especially in the quantitative assessment of small
airways dysfunction. Quantitative CT might gain an
important role in both phenotyping and (early) diagnosis of
COPD patients, which might lead to the detection of
treatable COPD subgroups and prevention of morbidity and
mortality due to this disease.
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